Ethan I. Meltzer

Neurology

1600 W 38th St
Ste 200
Austin, TX 78731

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Response to letter to the editor, re: Solving gaps in clinical reasoning is the cure to neurophobia in artificial intelligence.

Response to letter to the editor, re: Solving gaps in clinical reasoning is the cure to neurophobia in artificial intelligence.

Journal: Journal of the neurological sciences

Published: June 09, 2026

Riboflavin deficiency myelopathy.

Riboflavin deficiency myelopathy.

Journal: Journal of the neurological sciences

Published: February 19, 2026

Solving gaps in clinical reasoning is the cure to neurophobia in artificial intelligence.

Solving gaps in clinical reasoning is the cure to neurophobia in artificial intelligence.

Journal: Journal of the neurological sciences

Published: November 24, 2025

Case Reports of Teprotumumab as Treatment for Monoclonal Antibody-Induced Thyroid Orbitopathy.

Case Reports of Teprotumumab as Treatment for Monoclonal Antibody-Induced Thyroid Orbitopathy.

Journal: Reports (MDPI)

Published: October 11, 2025

Neurohospitalist Core Competencies.

Neurohospitalist Core Competencies.

Journal: The Neurohospitalist

Published: November 29, 2024

Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants.

Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants.

Journal: Brain : a journal of neurology

Published: January 01, 2024

Does GPT-4 have neurophobia? Localization and diagnostic accuracy of an artificial intelligence-powered chatbot in clinical vignettes.

Does GPT-4 have neurophobia? Localization and diagnostic accuracy of an artificial intelligence-powered chatbot in clinical vignettes.

Journal: Journal of the neurological sciences

Published: June 01, 2023

Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.

Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.

Journal: Multiple sclerosis and related disorders

Published: March 28, 2023

Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study.

Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: October 04, 2022

Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.

Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.

Journal: Neurology

Published: June 11, 2021

Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist.

Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist.

Journal: Current rheumatology reports

Published: March 23, 2021

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 07, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026